The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonorino, C.
Right arrow Articles by Wysocki, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonorino, C.
Right arrow Articles by Wysocki, L. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 1998, 161: 5210-5216.
Copyright © 1998 by The American Association of Immunologists

Characteristics of the Strong Antibody Response to Mycobacterial Hsp70: A Primary, T Cell-Dependent IgG Response with no Evidence of Natural Priming or {gamma}{delta} T Cell Involvement1

Cristina Bonorino2,*, Nance B. Nardi*, Xianghua Zhang{dagger},{ddagger} and Lawrence J. Wysocki{dagger},{ddagger}

* Department of Microbiology Pontificia Universidade Catolica do Rio Grande do SulAv, Porto Alegre, Brazil; {dagger} Department of Pediatrics, Division of Basic Sciences, National Jewish Medical and Research Center, Denver, CO 80206; and {ddagger} Department of Immunology, University of Colorado Health Sciences Center, Denver, CO 80262


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Despite its high degree of evolutionary conservation, hsp70 is a surprisingly robust Ag, to such a degree that it is under consideration as a potential substrate in vaccine development. The cellular basis of the strong humoral response, however, is unknown, although it is often hypothesized to derive from restimulation of memory T cells that have been primed by hsp of intestinal flora. In this study, we tested this hypothesis and performed additional studies on the immune response to hsp70 of Mycobacterium tuberculosis. Superficially, the primary Ab response to this protein resembles a T cell-dependent secondary one, constituted almost exclusively by IgG. However, there is no evidence of natural priming, as revealed both by in vitro stimulation experiments and by immunity in germfree mice. Although hsp70 stimulates {gamma}{delta} and {alpha}ß T cells from unprimed mice to proliferate in vitro, {gamma}{delta} cells are not required for the strong humoral response, which is indistinguishable in normal and {gamma}{delta} T cell-deficient mice. Thus, the unusual immunogenicity of this protein in eliciting a humoral response appears to be due to a strong {alpha}ß T cell response with no evidence of natural priming or a {gamma}{delta} T cell involvement.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Heat shock proteins (hsps)3 of the hsp70 family are extremely well conserved, to the extent that they are often exploited for evolutionary relationship studies (1). Given the observation that immunity is associated with foreignness, it is a paradox that hsps are major immunogens in several parasitic infections, such as those by Plasmodium (2, 3, 4), Trypanosoma (5), and mycobacteria (6, 7). In addition, hsp70 of Mycobacterium tuberculosis apparently possesses adjuvant properties when used as a carrier in immunizations. This is revealed by IgG responses generated in mice (8) and squirrel monkeys (9) to Ags conjugated to this protein either chemically or via gene fusion (10). Finally, correlations between the presence of Abs or T cells against this protein and autoimmune diseases have been reported (11, 12), and it is known that HLA-DR alleles expressed by most patients with rheumatoid arthritis bind both their own and Escherichia coli hsp70 (13).

The molecular mechanisms by which hsp70 exerts immunogenicity in vivo as well the identity of the cellular targets, however, are unknown. Hsps have been associated with {gamma}{delta} T cell responses (14, 15, 16), and in mice, mycobacterial hsp70 stimulates intestinal {alpha}ß and {gamma}{delta} T cells (17). These observations have led investigators to hypothesize that the immune system is naturally primed by hsp70 of gut flora (18, 19). Accordingly, the apparent "adjuvanticity" of hsp70 could be simply a consequence of stimulating previously generated memory T cells.

To fully exploit the potential of this protein in vaccine design and to avoid potential autoimmune complications, it is necessary to understand the mechanisms through which hsp70 interacts with and stimulates the immune system. In this article, we report that the strong humoral immune response to hsp70 itself is associated with {alpha}ß T cells. {gamma}{delta} T cells, although stimulated by hsp70, are not required for the humoral response to hsp70. Finally, it appears that animals are not naturally primed by gut floral hsp, since germfree mice are able to mount an IgG response to hsp70 that is comparable with the one mounted by non-germfree controls and because there is no evidence of hsp-specific {alpha}ß T cell expansions in animals that are not deliberately immunized.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

The following specific pathogen-free (SPF) mice were purchased from The Jackson Laboratories (Bar Harbor, ME) and maintained at the National Jewish Biological Resource Center animal facility: BALB/c, C57BL/6, B10.BR, C3H/HeJ, BALB/c nu/nu and +/nu, Tcrb/Tcrb (TCRß-deficient on a C57BL/6 background), and TCR{delta}-deficient on a mixed 129 x C57BL/6 background. Germfree Black Swiss mice, as well as SPF age- and sex-matched Black Swiss controls, were purchased from Taconic Farms (Germantown, NY) and maintained in a sterile isolator at the National Jewish Biological Resource Center. The germfree condition of the animals was monitored daily by culture of fecal samples on blood agar plates. All mice were female and between 6 and 12 wk of age except for the Tcrb/Tcrb mice and heterozygous littermates, which were male.

Ags and mitogens

Recombinant hsp70 from M. tuberculosis was provided by the World Health Organization and also purified by us from cultures of E. coli transformed with plasmid pY3111 (a gift from Dr. Douglas Young), as described (20), followed by passage through a Detoxi Gel column (Pierce, Rockford, IL) to eliminate potential endotoxin. IFA, CFA, keyhole limpet hemocyanin (KLH), OVA, LPS, and polymyxin B were purchased from Sigma (St. Louis, MO).

Immunizations

Ag was delivered in a total volume of 200 µl. Mice were immunized by i.p. injection with 1, 5, or 20 µg of Ag, in PBS alone or emulsified with IFA or CFA. Serum was obtained from tail artery blood.

Antibodies

The following mAbs, provided by investigators from the National Jewish Medical and Research Center and used for FACS analysis, were purified from hybridoma culture supernatants and conjugated to biotin: 53.7 (anti-CD5) (21) (American Type Culture Collection, Manassas, VA), 53.6 (anti-CD8) (21), RA3-6B2 (anti-B220) (22) and BET-2 (anti-IgM) (23), H57-597 (anti-TCR-{alpha}ß) (24), GK1.5 (anti-CD4) (25), 145-2C11 (anti-CD3) (26), and 405A10 (anti-{gamma}{delta} TCR) (27). Anti-bromodeoxyuridine (BrdUrd) mAb conjugated to FITC was purchased from Becton Dickinson (San Jose, CA). Allotype-specific anti-isotype mAbs, conjugated to biotin or to alkaline phosphatase (AKP), were purchased from PharMingen (San Diego, CA). The following mAbs, previously produced and purified by the senior author (L.J.W.), were used as isotype controls: P65D6-3 mouse IgM, anti-p-azophenylarsonate (Ars); mAb 36-65 mouse IgG1, anti-Ars; P65D6-5 mouse IgG2a anti-Ars; and HPSuf-1 mouse IgG2b, anti-p-azophenylsulfonate (Sulf). Goat anti-IgM and anti-IgG, not labeled or AKP conjugated, were purchased from Sigma.

ELISA

Ninety-six-well plates (Becton Dickinson) were coated with hsp70, 2 µg/ml in PBS, overnight at 4°C. Both these and control uncoated plates were incubated with blocking buffer (PBS with 0.02% BSA, 0.01% gelatin, 0.05% Tween-20, and 0.02% thimerosal) for at least 30 min at room temperature. After washing with PBS, serial dilutions of mouse sera in blocking buffer were incubated (50 µl/well) in duplicate at room temperature for 1 h. The highest concentration of serum tested was a dilution of 1:50. Plates were washed six times with PBS and incubated for another hour at room temperature with specific anti-isotypes labeled either with biotin or AKP. When biotinylated Ab was used, an extra step of washing and incubating with streptavidin-AKP (PharMingen), diluted in blocking buffer, for 1 h at room temperature was performed. Bound Abs were developed using substrate for AKP (Sigma) diluted to 0.5% in a buffer consisting of 1 M Tris base, 0.5 mM zinc chloride, and 2 mM magnesium chloride. ODs were read after 2 h in an ELISA reader (model 2550; Bio-Rad, Richmond, CA) at 410 nm, and the last positive dilution was determined. Isotype reagents were tested with mAbs directed to Ars and Sulf listed above, using haptenated BSA-coated wells or hsp70-coated wells (control).

Cell preparation

Single-cell suspensions of spleen or lymph node cells were obtained by disruption of the organs between frosted microscope slides in RPMI supplemented with FCS (5%). Bone marrow was obtained from femurs by flushing with the same medium using a needle and syringe. After two washes, red cells from spleen and bone marrow were lysed with ammonium chloride. Peritoneal cells were obtained by injecting ice-cold PBS with 2% FCS and recovering the injected volume with a Pasteur pipette. All cells were washed three additional times with medium and counted in a Coulter Counter (Hialeah, FL). T cells were purified by two passages through nylon wool (28), with purity determined by FACS after each passage. Percentages of CD3+ cells were approximately 35–45% before nylon wool purification, 80–85% after the first passage, and 90–95% after the second passage.

Enzyme-linked immunospot (ELISPOT) assay

An ELISPOT assay was performed as described (29), with the following modifications. Ninety-six-well flat-bottom plates (Fisher, Pittsburgh, PA) were coated with Ag, 5 µg/ml in PBS overnight at 4°C, and blocked for 30 min at 37°C with PBS made 5% in powdered skim milk. After washing with PBS, cells isolated as described above were plated in serial dilutions in RPMI without FCS. After incubation for 3–5 h at 37°C with 5% CO2 in air, the cells were removed, and the plates were washed extensively with PBS and incubated for 1 h at room temperature with specific anti-isotype Abs conjugated to AKP diluted in PBS made 1% in powdered skim milk. After extensive washing with PBS, the bound Abs were developed with BCIP (5-bromo-4-chloro-3-indolyl-phosphate; Sigma) diluted to 1 mg/ml in 50 ml AMP buffer (Sigma), with incubation for 1–3 h at 37°C. The plates were then washed with water and air dried, and the spots were counted using an inverted microscope. The frequency of Ab-forming cells in 106 total cells was calculated through a linear regression. Reagents were tested using the anti-Ars and anti-Sulf hybridomas listed above on haptenated BSA-coated wells or hsp70-coated wells (controls).

Adoptive transfers

BALB/c mice (Igha) were irradiated with 560 rads and used as recipients of single-cell suspensions of spleen and/or peritoneal cells isolated from other BALB/c mice or from C.B17 mice (Ighb). Recipients had 2 x 107 spleen cells/individual delivered by tail vein injection, in 200 µl of RPMI without sera, and/or 2 x 106 peritoneal cells injected i.p.

Proliferation assays

Spleen cells of mice with or without immunization were resuspended in RPMI with 10% FCS at a concentration of 1.25 x 106 cells/ml and cultivated for 72 h at 37°C in 5% CO2 with 12.8 µg/ml of hsp70 or molar equivalents of control Ag. Cells destined for quantification of [3H]thymidine incorporation were plated in triplicate. After 72 h, 1 µCi of [3H]thymidine (ICN, Irvine, CA) was added to each well; the cells were harvested 8 h later in a printed Filtermat A (Wallac, Turku, Finland), and the incorporation was determined in a Microbeta 1450 (Wallac). Cells destined for flow cytometry were plated in petri dishes, 10 ml/plate, 1.25 x 106 cells/ml, with Ag as described above. For BrdUrd incorporation assays, 20 µg/ml BrdUrd (Sigma) was added after 72 h of culture. The cells were then incubated for 8 h, centrifuged in Ficoll-Hypaque (Pharmacia, Piscataway, NJ), resuspended to 5 x 105 cells/ml in T cell medium, and stimulated with 50 U of recombinant IL-2 (Becton Dickinson) for 12 h before harvest and analysis by FACS.

In some assays, T cells were purified as described above, resuspended to 4 x 106/ml in RPMI without sera, and plated in 96-well tissue culture plates (Fisher) (100 µl/well) with an equal number of irradiated (3000 rads) spleen cells (100 µl/well) serving as APC. Ag was added in PBS in a volume of 20 µl/well. After 24 h of culture at 37°C in 5% CO2, 20 µl/well of FCS was added. One µCi of [3H]thymidine (ICN) was added to each well 3 days later, and incorporation was measured 24 h later as described above.

Flow cytometry

Cells (5 x 106 cells/ml) prepared as described above were washed three times with staining buffer (cold PBS with 2% FCS, 0.1% NaN3) and incubated with mAbs conjugated to biotin or FITC for 20 min on ice. They were then washed and incubated with streptavidin-phycoerythrin (Becton Dickinson) for another 20 min. After three more washes, the cells were analyzed on a Coulter 751 flow cytometer (Hialeah, FL) with CICERO acquisition software (Cytomation, Ft. Collins, CO).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
A primary response to hsp70 with properties of a secondary response to conventional Ag

BALB/c mice that were immunized i.p. with 20 µg of hsp70 in IFA produced high titers of IgG anti-hsp70 as early as 7 days after immunization (Fig. 1Go). Titers commonly reached 4,000 at day 7 before climbing to ~20,000 on day 28 (Fig. 2Go). The response was T cell dependent, as deduced from its absence in nude mice and in TCR ß-deficient mice (Fig. 1Go). Contrary to what was observed upon immunization with conventional Ag (OVA or KLH), IgM was below detection in this assay, in which sera were titered starting at a dilution of 1/50 (Fig. 1Go). This strong day 7 IgG response occurred reproducibly in other mouse strains. In particular, its occurrence in C3H/HeJ mice, which are insensitive to LPS, argues against a potential role for endotoxin (Fig. 3Go). The strength of response was immunogen dose dependent, at least up to ~20 µg, when delivered in IFA (Fig. 2Go). If the Ag was delivered i.v., titers were lower and more variable, but the day 7 IgG response could still be detected in some animals. Western blotting analysis confirmed that sera of animals immunized with hsp70 reacted exclusively with a 70-kDa protein (data not shown).



View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 1. Titers and T cell dependence of anti-hsp70 Ab response. Groups of three BALB/c wild-type, BALB/c nu/+, BALB/c nu/nu, C57BL/6J Tcrb/Tcrb (ß-/ß-), and C57BL/6J Tcrb/+ (ß-/+) mice were immunized i.p. with M. tuberculosis hsp70, IFA alone, OVA, or KLH, or not immunized as indicated, and bled 7 days later; titers of specific serum IgM and IgG to the immunizing Ag were determined by ELISA. Ag was always delivered as an emulsion of 20 µg in IFA.

 


View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 2. Dose dependence of anti-hsp70 response. Groups of three BALB/c mice were bled and then immunized i.p. with either 1, 5, or 20 µg of hsp70 in IFA. The mice were bled again 7 and 28 days later, and Ab titers to hsp70 were determined by ELISA.

 


View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 3. Conservation of the strong day 7 anti-hsp70 response. Groups of three mice from different strains were immunized i.p. with 20 µg of hsp70 in IFA and bled 7 days later, and the titers of specific serum IgM and IgG were determined by ELISA.

 
Cells involved in the strong response to hsp70

Contrary to what would be expected if the response were anamnestic, there was no detectable anti-hsp70 Ab in preimmune serum (Fig. 1Go), and none was observed until day 7 after immunization, when the Ab was already IgG. In spite of this, cells producing IgM that apparently binds hsp70 were detected by ELISPOT assay before immunization. They were more abundant in the peritoneum than in the spleen (Table IGo). Their frequency increased upon immunization. Immunization also resulted in the appearance of cells secreting IgG anti-hsp70 in the spleen but not in the peritoneum. The discrepancy between IgM-secreting cells and the apparent absence of anti-hsp70 IgM in the serum of both preimmune and immunized animals is unknown but could be due to abortive activation; rapid isotype switching; or secretion of low-affinity, polyreactive IgM by B1 cells. In this regard, we have noted that the IgM spots tend to be very small. If the serum contained any anti-hsp70 IgM, however, it was present only at low levels, because we could not detect it at a dilution of 1:50.


View this table:
[in this window]
[in a new window]
 
Table I. Frequency of anti-hsp70 cells before and after immunization (per 106 cells)1

 
To determine the contribution of splenic and peritoneal cells to the anti-hsp70 Ab response, adoptive transfer experiments were performed. Irradiated, BALB/c mice received the following combinations of normal BALB/c cells: splenocytes only, peritoneal cells only, splenocytes plus peritoneal cells, and no cells. The recipients were immunized once with 20 µg of hsp70 in IFA 24 h later and were bled 13 days following the primary immunization. (Mice that were reconstituted under these conditions first produced detectable Ab on day 9.) Sera were tested for anti-hsp70 Ab. Spleen cells alone reconstituted the strong IgG response, while no response was detected in animals reconstituted with peritoneal cells alone (Fig. 4Go). Variations of this experiment were performed with similar outcomes six times, including one experiment in which splenic and peritoneal cells were distinguished by Ig allotype differences (data not shown).



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 4. Reconstitution of the strong hsp70 Ab response by splenic cells. Groups of three BALB/c mice were irradiated with 570 rads and reconstituted with either no cells, BALB/c spleen cells alone, BALB/c peritoneal cells alone, or a combination of both. The mice were immunized i.p. 24 h later with 20 µg of hsp70 in IFA and bled 13 days following immunization. Serum Ab titers to hsp70 were determined by ELISA.

 
The absence of hsp70-binding B cells of the {gamma} isotype in unimmunized mice and the lack of an Ab response in nude and TCR ß-deficient mice suggested that the unusual character of the hsp70 response might be attributed to Th cells. This was supported by an experiment in which the strong response was elicited to a new epitope introduced to hsp70. Mice were immunized with hapten conjugates (Ars) of either hsp70 or a control carrier (KLH). The rapid IgG response with no detectable accompanying IgM response was elicited to Ars by immunization with Ars-hsp70 (Fig. 5GoA). In contrast, mice immunized with Ars-KLH (Fig. 5GoB) showed a typical primary anti-Ars response of predominantly IgM. While titers of anti-Ars and anti-hsp IgG were not as high in mice immunized with Ars-hsp70 as Ab titers to hsp70 in preceding experiments, this may well be due to damage to the carrier hsp70 during the hapten conjugation, since the titers of both Abs were depressed to a comparable degree. Imparting strong immunogenicity to the Ars hapten by conjugating it to the hsp70 carrier implies that the peculiarities of the anti-hsp70 humoral response are most likely a function of Th cells.



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 5. Properties of anti-hsp70 response conferred by carrier effect. Mice were immunized i.p. with 20 µg of either Ars-hsp70 (A) or Ars-KLH (B) in IFA and bled on days 7 and 14 after immunization, and the Ab titers to the hapten and to each carrier were determined by ELISA.

 
The T cell response to hsp70

We next examined the effect of hsp70 on splenic T cells in vitro. T cells purified from spleen of unprimed BALB/c mice were incubated with different concentrations of hsp70, using irradiated total spleen cells as a source of APC. A dose-dependent proliferation measured by incorporation of [3H]thymidine was detected (Fig. 6Go). Unexpectedly, proliferation was also observed in cultures consisting of T cells and Ag, without the deliberate addition of APC. However, in these cultures 90–95% of the cells were CD3+, leaving open the possibility that residual APC contributed to some or all of the observed proliferation. To address the possibility that proliferation might be due to contaminating LPS, we cultured total spleen cells from unimmunized BALB/c and C3H/HeJ mice with hsp70 alone, hsp70 plus polymyxin B, or a control Ag (OVA). In BALB/c mice, in which LPS-induced proliferation was almost completely inhibited by polymyxin B (Fig. 7GoA), the addition of polymyxin B to the hsp70-stimulated cultures reduced [3H]thymidine incorporation by approximately 50% (Fig. 7GoB). On the other hand, in C3H/HeJ mice, which are hyporesponsive to endotoxin, hsp70 still induced proliferation of spleen cells from unprimed mice, and the addition of polymyxin B to the cultures did not have an effect on [3H]thymidine incorporation (Fig. 7GoC). These results indicate that a significant amount of proliferation occurs that cannot be attributed to contamination by endotoxin. They also suggest that some of this proliferation may be APC independent, although this is not crucial to any subsequent argument we wish to make.



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 6. Proliferation of splenic T cells from unimmunized mice in response to hsp70. Nylon wool-purified splenic T cells (93% CD3+) from unimmunized BALB/c mice were cultured for 3 days with different quantities of mycobacterial hsp70 and with or without total splenic cells irradiated with 3000 rads as an APC source. Proliferation was measured by [3H]thymidine incorporation.

 


View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 7. The stimulating effect of mycobacterial hsp70 is not solely due to contaminant endotoxin. A, BALB/c splenic cells incubated with either LPS alone or LPS with 5 µg of polymyxin B/well. Unseparated BALB/c (B) and C3H/HeJ (C) splenocytes were cultured with different concentrations of either hsp70, hsp70 + polymyxin B (5 µg/ml), or OVA (control Ag) for 3 days (B and C). The proliferation was measured by [3H]thymidine incorporation.

 
Cells stimulated in vitro with hsp70 were analyzed by flow cytometry to identify proliferating cell types. The populations that increased in frequency upon specific incubation with hsp70 were primarily {gamma}{delta} T cells and B cells (data not shown). Given these results and previous reports implicating a role for {gamma}{delta} T cells in immunity to hsps, we sought to determine whether {gamma}{delta} T cells might be playing a role in the development of the humoral immune response in vivo. To this end, we immunized TCR {delta}-deficient (Tcrd) mice with hsp70. The results indicate that {gamma}{delta} T cells are not required for the strong rapid anti-hsp70 humoral response, because the deficient mice and the heterozygote littermates responded similarly (Fig. 8Go). Concurrently, proliferation in response to hsp70 by cells derived from Tcrd mice was reduced by approximately 44% relative to heterozygote littermate controls (Fig. 9Go). This reduction is close to the proportion of BrdUrd incorporation attributed to {gamma}{delta} T cell division in culture assays, as seen in the top half of Table IIGo.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 8. A strong Ab response to mycobacterial hsp70 in the absence of {gamma}{delta} T cells. {gamma}{delta} T cell-deficient mice on a mixed 129 x C57BL/6 background, with their respective wild-type littermate controls, were immunized with 20 µg of hsp70 and bled 7 days later. Specific Ab titers were determined by ELISA.

 


View larger version (40K):
[in this window]
[in a new window]
 
FIGURE 9. Proliferation by cells from {gamma}{delta} T cell-deficient mice in response to hsp70. Total spleen cells from either TCR {delta}-deficient mice or heterozygote littermate controls were cultured with different concentrations of hsp70 or OVA (control Ag) for 3 days. Proliferation was measured by [3H]thymidine incorporation.

 

View this table:
[in this window]
[in a new window]
 
Table II. Effect of immunization on the in vitro proliferation of BALB/c spleen cells in response to hsp701

 
These observations, taken together with the absence of the response in nude and TCR ß-deficient mice (Fig. 1Go), suggested that the strong Ab response to hsp70 is dependent upon {alpha}ß T cells. If so, then hsp70 should induce a strong proliferation of {alpha}ß T cells taken from hsp70-primed mice. To test this prediction, we set up an assay to measure [3H]thymidine incorporation. To be sure that actual proliferation was being measured, as opposed to preferential survival in vitro, a staining assay for surface markers was also conducted in concert with BrdUrd incorporation. Total spleen cells from unimmunized BALB/c mice or from mice immunized with hsp70 14 days previously were cultured with either hsp70 or OVA (Table IIGo). In this experiment, hsp70 stimulated proliferation of both {gamma}{delta} T cells and B220+ cells as suggested by preceding cell recovery experiments (data not shown). However, the proliferation index was virtually the same regardless of whether these cells were derived from immunized or unimmunized mice. On the other hand, relative proliferation of {alpha}ß T cells to hsp70 was significant only for cells derived from hsp70-immunized mice (Table IIGo). These data confirm the results of the previous frequency analysis, and they suggest that the stimulating effect of hsp70 on {gamma}{delta} cells and B cells in vitro was not necessarily related to the humoral response. Importantly, the results also indicate that previous natural priming was probably not the explanation for the strong, rapid IgG response to hsp70. If priming had occurred, no difference in {alpha}ß T cell proliferation would be expected between unimmunized and deliberately immunized mice.

The anti-hsp70 response in germfree animals

In a second test of the natural priming hypothesis, we immunized three groups of germfree black Swiss mice and sex-/age-matched SPF controls and bled the animals 7 days later. The germfree and control mice produced strong and comparable Ab responses to hsp70 (Fig. 10Go). Thus, the strong IgG response and lack of IgM appear to be independent of the presence of natural gut flora, in argument against the natural priming hypothesis.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 10. Germfree mice respond to mycobacterial hsp70 as strongly as their non-germfree controls. Black Swiss germfree mice and matched SPF controls were immunized with 20 µg of hsp70 and bled 7 days later. Specific Ab titers were determined by ELISA.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study we have explored the cellular basis of the unusually strong humoral response to hsp70 of M. tuberculosis, which manifests attributes of a secondary response to conventional Ag. Our results indicate that although diverse lymphocyte types respond to this Ag, the strong humoral component is possibly due to a robust population of {alpha}ß Th cells. There is no evidence that Th cells have been naturally primed by gut floral hsp70, as revealed both in proliferation assays and by conservation of the response in germfree animals. We cannot formally exclude the possibility that natural priming might have occurred orally with dietary hsp70 protein or peptide fragments thereof. However, we consider this unlikely because the strong response was reconstituted with splenocytes, because there was a clear difference in the extent of {alpha}ß T cell proliferation between cells of deliberately primed and unprimed mice, and because we have been unable to influence the response by deliberate oral administration of hsp70 (unpublished observation). In addition, oral routes of Ag delivery are more likely to induce tolerance rather than immunity (30, 31).

The comparable responses to hsp70 observed in germfree and control mice lead us to believe that natural priming to hsp70 by gut flora has not occurred. We believe this finding is in agreement with clues present in the literature. In a recent study of spontaneously colitic mice, Brandwein et al. (32) identified major bacterial Ags recognized during the course of the disease, none of which had a mass of 70 kDa. Hsp70 and hsp65 are coordinately induced in response to the same stimuli (33). In some species of bacteria, they are encoded in the same operon and, consequently, cotranscribed (34). Natural priming by one hsp should therefore be accompanied by natural priming to the other, whether by gut flora or by dietary hsp. Yet the capacity of hsp70 to function as an exceptionally strong carrier protein is not paralleled by hsp65, despite the fact that the latter is potentially immunogenic (7, 8) and that peptides able to bind class II MHC have been identified from both of these bacterial hsps (35, 36, 37).

We expected that natural priming by hsp70 might lead to natural serum Ab or to IgG-expressing memory cells, but neither of these were detectable in unimmunized mice. B cells producing IgM that apparently binds hsp70 were observed by ELISPOT assay; however, the results of adoptive transfer experiments argue against their role in the strong response. These cells were present at highest frequency in the peritoneum, and when transferred to adoptive hosts, they did not directly contribute to the serum Ab response to hsp70. The spontaneous peritoneal Ab-forming cells are also missing in CBA/N (xid) mice that displayed the strong response to hsp70 (unpublished observation). Additional ELISPOT assays revealed a comparable frequency of peritoneal precursor B cells capable of producing Ab to conventional Ags (unpublished observation), suggesting that the majority of Ag-reactive peritoneal cells belong to the B1 subset, which have a propensity to be polyreactive (38). It is possible that we simply could not detect anti-hsp70 serum IgM because of limitations in our ELISA (we have tested serum at concentrations higher than 1:50 because of signal-to-noise problems). Furthermore, there is also a possibility that the IgM produced by cells detected by ELISPOT remains sequestered in the tissue. ELISPOT is often used to detect Ab-forming cells even when no specific serum Ab can be detected (39, 40). Based on isotype specificity controls, as well as on the experiments with CBA/N (xid) mice, however, we think that cells detected in the ELISPOT assay before immunization may be polyreactive B1 cells rather than precursors to IgG anti-hsp70 Ab-forming cells. The increased frequency of IgM cells detected in immunized mice is also puzzling. The spots generated by these cells are small, which might indicate that they are polyreactive, abortively activated and dying, or rapidly switching isotype before significant IgM secretion.

It has been demonstrated that hsp70 is a favored immunogenic target and that hsp70 can function as an immunogenic carrier for peptide epitopes (2, 3, 4, 5, 6, 7, 8, 9, 10). Our data are in agreement with these findings. We have shown that the primary response to this protein has the characteristics of a secondary response to conventional Ag, that the response to hsp70 is {alpha}ß T cell dependent, and that hsp70 functions as a strong carrier for primary anti-hapten Ab responses. We have also observed that the response is conserved among different inbred strains of mice, indicating that hsp70 can retain its strong stimulatory effect in the context of different MHC class II alleles and in strains that differ in propensity for a Th1- or Th2-type response. Finally, we have excluded the possibility of the response being due to contaminant endotoxin, since the characteristics of the strong response are conserved in C3H/HeJ mice.

One of our most surprising findings was the lack of a requirement for {gamma}{delta} T cells in the strong humoral response to hsp70. Several investigators have identified {gamma}{delta} T cell populations that respond to this protein, and results of our in vitro proliferation assays are in agreement with these earlier reports. Moreover, Pao et al. (41) have provided evidence that {gamma}{delta} T cells may function to provide help to Ag-specific B cells. Nevertheless, we found that mice lacking these cells due to a targeted disruption of the {delta} chain gene (42) responded to immunization with hsp70 equivalently to {delta} chain-intact congenic controls. The proliferation of {gamma}{delta} T cells induced by hsp70 was significant and did not differ between unprimed and primed mice (Table IIGo). This, together with the significant difference in proliferation of {alpha}ß T cells derived from naive and hsp70-primed animals, suggests that strong proliferation to hsp70 by {gamma}{delta} T cells is an innate rather than an acquired characteristic.

If the strong, rapid response to hsp70 is not due to natural priming or innate features of {gamma}{delta} T cells, what is it due to? Epitope mapping studies for the hsp70 of M. leprae suggest the presence of several stimulatory epitopes in the C-terminal region of the protein for both mice and humans (36, 37, 43, 44). It is possible that the same holds true for M. tuberculosis hsp70 and other parasitic hsp analogues. An alternative but more complex possibility is that the biologic function of hsp70 plays a role in its own presentation. Hsps of the 70-kDa family have been implicated in different steps of Ag processing/presenting pathways. Hsp70 seems to be directly involved in MHC class I loading (45, 46), as well as in lysosomal degradation of intracellular proteins (47) and Ag processing (48). Heat shock itself has been associated with Ag processing and presentation (49, 50, 51). The particular immunogenicity of hsp70 could reflect the combination of its particular structure with its role in Ag presentation. These intriguing possibilities are currently under investigation.


    Acknowledgments
 
We thank Willi Born and Diana Smith for reviewing this manuscript, Tony Vella for insights regarding the proliferation assays, Jennifer Kench for helping us to set up the BrdUrd assay, Doreen Jumbeck for her help with the germfree mice, Bill Townend for help with cytometry, Douglas Young for the plasmid, and the World Health Organization for providing the hsp70 protein.


    Footnotes
 
1 This work was funded by National Institutes of Health Grant RO1AI39563 (to L.J.W.). C.B. was supported by a scholarship from Conselho Nacional de Pesquisas, Brasil. Back

2 Address correspondence and reprint requests to Dr. Cristina Bonorino, Department of Microbiology Pontificia Universidade Catolica do Rio Grande do SulAv, Ipiranga 6681, Sala 21290619, 900 Porto Alegre RS, Brazil. E-mail address: Back

3 Abbreviations used in this paper: hsp, heat shock protein; KLH, keyhole limpet hemocyanin; BrdUrd, bromodeoxyuridine; AKP, alkaline phosphatase; Ars, p-azophenylarsonate; Sulf, p-azophenylsulfonate; ELISPOT, enzyme-linked immunospot. Back

Received for publication November 6, 1997. Accepted for publication July 9, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Gupta, R. S., B. Singh. 1992. Cloning of the hsp70 gene from Holobacterium marismortui: relatedness of archaebacterial hsp70 to its eubacterial homologs and a model for the evolution of the hsp70 gene. J. Bacteriol. 174:4594.[Abstract/Free Full Text]
  2. Dubois, P., J. P. Dedet, T. Fandeur, C. Roussillon, M. Jendoubi, S. Pauillac, O. Mercerau-Pujalon, L. Pereira da Silva. 1984. Protective immunization of the squirrel monkey against asexual blood stages of Plasmodium falciparum by use of parasite protein fractions. Proc. Natl. Acad. Sci. USA 81:229.[Abstract/Free Full Text]
  3. Mattei, D., A. Scherf, O. Bensaude, L. Pereira da Silva. 1989. A heat shock-like protein from the human malaria parasite Plasmodium falciparum induces autoantibodies. Eur. J. Immunol. 19:1823.[Medline]
  4. Kumar, N., Y. Zhao, P. Graves, J. Perez, L. Maloy Folgar, H. Zheng. 1990. Human immune response directed against Plasmodium falciparum heat shock-related proteins. Infect. Immun. 58:1408.[Abstract/Free Full Text]
  5. Engmann, D. M., L. V. Kirchoff, J. E. Donelson. 1989. Molecular cloning of mtp70, a mitochondrial member of the hsp70 family. Mol. Cell. Biol. 9:5163.[Abstract/Free Full Text]
  6. Britton, W. J., L. Hellqvist, A. Basten, A. L. Inglis. 1986. Immunoreactivity of a 70 kD protein purified from M. bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J. Exp. Med. 164:695.[Abstract/Free Full Text]
  7. Adams, E., R. J. Garsia, L. Hellqvist, P. Holt, A. Basten. 1990. T cell reactivity to the purified mycobacterial antigens P65 and P70 in leprosy patients and their household contacts. Clin. Exp. Immunol. 80:206.[Medline]
  8. Barrios, C., C. Georgopoulos, P.-H. Lambert, G. Del Giudice. 1994. Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen. Clin. Exp. Immunol. 98:229.[Medline]
  9. Perraut, R., A. R. Lussow, S. Gavoille, O. Garraud, H. Matile, C. Tougne, J. van Embden, R. van der Zee, P.-H. Lambert, J. Gysin, G. Del Giudice. 1993. Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants. Clin. Exp. Immunol. 93:382.[Medline]
  10. Suzue, K., R. A. Young. 1996. Adjuvant free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p-24. J. Immunol. 156:873.[Abstract]
  11. Minota, S., B. Cameron, W. J. Welch, J. B. Winfield. 1988. Autoantibodies to the constitutive 73-kD member of the hsp70 family of heat shock proteins in systemic lupus erythematosus. J. Exp. Med. 168:1475.[Abstract/Free Full Text]
  12. Salvetti, M., C. Butinelli, G. Ristori, M. Carbonari, M. Cherchi, M. Fiorelli, M. G. Grasso, L. Toma, C. Pozilli. 1992. T lymphocyte reactivity to the recombinant mycobacterial 65 and 70 kDa heat shock proteins in multiple sclerosis. J. Autoimmun. 5:691.[Medline]
  13. Auger, I., J. M. Escola, J. P. Gorvel, J. Roudier. 1996. HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins. Nat. Med. 2:306.[Medline]
  14. Born, W., L. Hall, A. Dallas, J. Boymel, T. Shinnick, D. Young, P. Brennan, R. O’Brien. 1990. Recognition of a peptide antigen by heat shock reactive gamma-delta T lymphocytes. Science 249:67.[Abstract/Free Full Text]
  15. Nagler-Anderson, C., L. A. McNair, A. Cradock. 1992. Self-reactive, T cell receptor {gamma}{delta}+ lymphocytes from the intestinal epithelium of weaning mice. J. Immunol. 149:2315.[Abstract]
  16. Kaufmann, S. H. E., D. Kabelitz. 1991. {gamma}{delta} T lymphocytes and heat shock proteins. Curr. Top. Microbiol. Immunol. 167:191.[Medline]
  17. Beagley, K. W., K. Fujihashi, C. A. Black, A. S. Lagoo, M. Yamamoto, J. R. McGhee, H. Kyono. 1993. The Mycobacterium tuberculosis 71-kDa protein induces proliferation and cytokine secretion by murine gut intraepithelial lymphocytes. Eur. J. Immunol. 23:2049.[Medline]
  18. Del Giudice, G.. 1996. In vivo carrier effect of heat shock proteins in conjugated vaccine constructs. W. van Eden, and D. B. Young, eds. Stress Proteins in Medicine Marcel Dekker, New York.
  19. Barrios, C., A. R. Lussow, J. van Embden, R. van der Zee, R. Appuoli, P. Constantino, J. A. Louis, P.-H. Lambert, G. Del Giudice. 1992. Mycobacterial heat shock proteins as carrier molecules. II. The use of the 70-kDa mycobacterial heat shock protein as a carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette-Guerin priming. Eur. J. Immunol. 22:1365.[Medline]
  20. Mehlert, A., D. B. Young. 1989. Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71-kD antigen, a member of the 70-kD heat-shock protein family. Mol. Microbiol. 3:125.[Medline]
  21. Ledbetter, J. A., L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.[Medline]
  22. Coffman, R. L., I. L. Weissman. 1981. A monoclonal antibody that recognizes B cells and B cell precursors in mice. J. Exp. Med. 153:269.[Abstract/Free Full Text]
  23. Kung, J. T., S. O. Sharrow, D. G. Sieckmann, R. Lieberman, W. E. Paul. 1981. A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody. J. Immunol. 127:873.[Abstract]
  24. Kubo, R. T., W. Born, J. Kappler. 1989. Characterization of a monoclonal antibody which detects all murine {alpha}ß T cells. J. Immunol. 142:2736.[Abstract]
  25. Dialynas, D.P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, F. W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445.[Abstract]
  26. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, J. A. Bluestone. 1987. Identification of a monoclonal specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.[Abstract/Free Full Text]
  27. Itohara, S., N. Nakanishi, O. Kanagawa, R. Kubo, S. Tonegawa. 1989. Monoclonal antibodies specific to native murine T cell receptor {gamma}{delta}: analysis of {gamma}{delta} T cells during thymic ontogeny and in peripheral lymphoid organs. Proc. Natl. Acad. Sci. USA 86:5094.[Abstract/Free Full Text]
  28. Julius, M. H., E. Simpson, L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus derived murine lymphocytes. Eur. J. Immunol. 3:645.[Medline]
  29. Sedgwick, D. J., P. G. Holt. 1983. A solid phase immuni-enzymatic technique for the enumeration of specific antibody secreting cells. J. Immunol. Methods 57:301.[Medline]
  30. Chen, Y., J. Inobe, H. L. Weiner. 1997. Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell. Immunol. 178:62.[Medline]
  31. Weiner, H.L.. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.[Medline]
  32. Brandwein, S. L., R. P. McCabe, Y. Cong, K. B. Waites, B. Ridwan, P. A. Dean, T. Ohkusa, E. H. Birkenmeier., J. P. Sundberg, C. O. Elson. 1997. Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol. 159:44.[Abstract]
  33. Yura, T., H. Nagai, H. Mori. 1993. Regulation of the heat shock response in bacteria. Annu. Rev. Microbiol. 47:321.[Medline]
  34. Yuan, G., S. L. Wong. 1995. Isolation and characterization of Bacillus subtilis groE regulatory mutants: evidence for orf39 in the dnaK operon as a repressor gene in regulating the expression of both groE and dnaK. J. Bacteriol. 177:6462.[Abstract/Free Full Text]
  35. Brett, S. J., J. Lamb, J. Cox, J. Rothbard, A. Mehlert, J. Ivanyi. 1989. Differential pattern of T cell recognition of the 65-Kda mycobacterial antigen following immunization with the whole protein or peptides. Eur. J. Immunol. 19:1303.[Medline]
  36. Adams, E., W. J. Britton, A. Morgan, A. L. Goodsall, A. Basten. 1993. Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70 KD antigen. Clin. Exp. Immunol. 94:500.[Medline]
  37. Peake, P. W., W. J. Britton, M. P. Davenport, P. W. Roche, K. R. McKenzie. 1993. Analysis of B-cell epitopes in the variable C-terminal region of Mycobacterium leprae 70-kilodalton heat shock protein. Infect. Immun. 61:135.[Abstract/Free Full Text]
  38. Casali, P., A. L. Notkins. 1989. Probing the human B cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu. Rev. Immunol. 7:513.[Medline]
  39. Link, H., S. Baig, Y. P. Jiang, O. Olsson, B. Hojeberg, V. Kostulas, T. Olsson. 1989. B cells and antibodies in MS. Res. Immunol. 140:219.[Medline]
  40. Bernstein, J. J., L. A. Willingham, W. J. Goldberg. 1993. Sequestering of immunoglobulins by astrocytes after cortical lesion abd homografting of fetal cortex. Int. J. Dev. Neurosci. 11:117.[Medline]
  41. Pao, W., L. Wen, L. Smith, A. Gulbranson-Judge, B. Zheng, G. Kelsoe, I. C. McLennan, M. J. Owen, A. C. Hayday. 1996. {gamma}{delta} T cell help of B cells is induced by repeated parasitic infection, in the absence of other T cells. Curr. Biol. 6:1317.[Medline]
  42. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. L. Lafaille, L. Wang, Y. Ichikawa, R. Janisch, M. L. Hooper, S. Tonegawa. 1992. Mutations in T cell antigen receptor genes {alpha} and ß block thymocyte development at different stages. Nature 360:225.[Medline]
  43. Davenport, M. P., K. R. McKenzie, A. Basten, W. J. Britton. 1992. The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses. Infect. Immun. 60:1170.[Abstract/Free Full Text]
  44. Adams, E., A. Basten, S. Rodda, W. Britton. 1997. Human T cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium specific epitopes rather than shared epitopes. Infect. Immun. 65:1061.[Abstract]
  45. Udono, H., P. K. Srivastava. 1993. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178:1391.[Abstract/Free Full Text]
  46. Srivastava, P. K., H. Udono, N. E. Blanchere, Z. Li. 1994. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39:93.[Medline]
  47. Chiang, H., S. R. Terlecky, C. P. Plant, J. F. Dice. 1989. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 246:382.[Abstract/Free Full Text]
  48. Van Buskirk, A., D. C. DeNagel, L. E. Guagliardi, F. M. Brodsky, S. K. Pierce. 1991. Cellular and subcellular distribution of PBP 72–74, a peptide binding protein that plays a role in antigen processing. J. Immunol. 146:500.[Abstract]
  49. Cristau, B., P. H. Schafer, S. K. Pierce. 1994. Heat shock enhances antigen processing and accelerates the formation of compact class II {alpha}ß dimers. J. Immunol. 152:1546.[Abstract]
  50. Michalek, M. T., B. Benacerraf, K. L. Rock. 1992. The class-II restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock. J. Immunol. 148:1016.[Abstract]
  51. Mariehoz, E., F. Tacchini-Cottier, M. Jacquier-Sarlin, F. Sinclair, B. S. Polla. 1994. Exposure of monocytes to heat shock does not increase class II expression but modulates antigen-dependent T cell responses. Int. Immunol. 6:925.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Med MicrobiolHome page
R. Duarte, A. M. Silva, L. Q. Vieira, L. C. C. Afonso, and J. R. Nicoli
Influence of normal microbiota on some aspects of the immune response during experimental infection with Trypanosoma cruzi in mice
J. Med. Microbiol., August 1, 2004; 53(8): 741 - 748.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Maranon, L. Planelles, C. Alonso, and M. C. Lopez
HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis
Int. Immunol., December 1, 2000; 12(12): 1685 - 1693.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Julia, S. S. McSorley, L. Malherbe, J.-P. Breittmayer, F. Girard-Pipau, A. Beck, and N. Glaichenhaus
Priming by Microbial Antigens from the Intestinal Flora Determines the Ability of CD4+ T Cells to Rapidly Secrete IL-4 in BALB/c Mice Infected with Leishmania major
J. Immunol., November 15, 2000; 165(10): 5637 - 5645.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
S. Tanaka, S. Itohara, M. Sato, T. Taniguchi, and Y. Yokomizo
Reduced Formation of Granulomata in {gamma}{delta} T Cell Knockout BALB/c Mice Inoculated with Mycobacterium avium subsp. paratuberculosis
Vet. Pathol., September 1, 2000; 37(5): 415 - 421.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonorino, C.
Right arrow Articles by Wysocki, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonorino, C.
Right arrow Articles by Wysocki, L. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*